Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic Epidural Analgesia for CABG
NCT04244435Phase 1Unknown
- Sponsor
- Volgograd State Medical University
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of ropivacaine in coronary artery occlusion (CAO) (3 arms), sponsored by Volgograd State Medical University. Primary endpoints: Hospital mortality at 1 year, Hospitalization duration at 1 year and 1 more. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
coronary artery occlusion (CAO)
Beyond the preview
Go deeper on NCT04244435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04244435.